70375-EN Rev B
15
3
Patient Treatment and Clinical
Information
This chapter provides information on the use of the TxCell
®
Scanning Laser Delivery System for the
treatment of ocular pathologies, including specific indications and contraindications, procedural
recommendations, and a list of clinical references. The information in this chapter is not intended to be all-
inclusive, nor is it intended to replace surgeon training or experience.
Intended Use/Indications for Use
When the TxCell Scanning Laser Delivery System is connected to the IQ 532
®
(532 nm) or the IQ 577
®
(577
nm) Laser Console, from the Iridex Family of IQ Laser Systems and used to deliver laser energy in CW-
Pulse, MicroPulse
®
or LongPulse mode, it i s intended to be used by a trained ophthalmologist for
the treatment of ocular pathology of both the anterior and posterior segments of the eye.
532 nm
Indicated for retinal photocoagulation, laser trabeculoplasty, iridotomy, iridoplasty including:
Retinal photocoagulation (RPC) for the treatment of:
Diabetic retinopathy, including:
Nonproliferative retinopathy
Macular edema
Proliferative retinopathy
Retinal tears and detachments
Lattice degeneration
Age-related macular degeneration (AMD) with choroidal neovascularization (CNV)
Sub-retinal (choroidal) neovascularization
Central and branch retinal vein occlusion
Laser trabeculoplasty for the treatment of:
Primary open angle glaucoma
Laser iridotomy, iridoplasty for the treatment of:
Angle closure glaucoma
